DIRECTOR, RESEARCH AND DISCOVERY

Dr. Simone Oostindie is Director, Research and Discovery at Gyes B.V., a biotechnology company that focuses on creating a pioneering Multispecific Antibody Platform (MAP) to discover and develop differentiated antibody therapeutics. Before Joining Gyes B.V. in 2023, Dr. Oostindie was a Sr. Scientist in the Translational Research department at Genmab, where she led the translational research and biomarker strategy for Genmab’s (pre)clinical therapeutic antibody candidates.

During her career at Genmab, she was involved in the discovery and development of novel antibody technology platforms including DuoHexaBody® and HexElect® and in the preclinical development of multiple therapeutic antibody candidates currently progressing in the clinic.

Dr. Oostindie received her PhD in immunology from Leiden University, with a focus on avidity engineering as a rational design principle for potentiated antibody therapeutics.